Myocardial flow regulation in people with mitochondrial myopathy, encephalopathy, lactic acidosis, stroke-like episodes/myoclonic epilepsy and ragged red fibers and other mitochondrial syndromes

Coronary Artery Disease

Volumn 14, Issue 3, 2003, Pages 197-205

  Tawakol, Ahmed ^a   Sims, Katherine ^a   MacRae, Calum ^a   Friedman, Jennifer R ^a   Alpert, Nathaniel M ^a   Fischman, Alan J ^a   Gewirtz, Henry ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Metabolic flow regulation; Mitochondria; Myocardial blood flow

Indexed keywords

ADENOSINE TRIPHOSPHATE; AMMONIA; LACTIC ACID; NITROGEN 13;

ADULT; ARTICLE; BRAIN DISEASE; CLINICAL ARTICLE; FEMALE; HEART MUSCLE BLOOD FLOW; HEART MUSCLE METABOLISM; HUMAN; LACTIC ACIDOSIS; MALE; MELAS SYNDROME; MERRF SYNDROME; METABOLIC REGULATION; MITOCHONDRIAL MYOPATHY; MYOCLONUS EPILEPSY; POSITRON EMISSION TOMOGRAPHY; PRIORITY JOURNAL; STROKE; SYNDROME DELINEATION;

ACIDOSIS, LACTIC; ADULT; BIOLOGICAL MARKERS; BLOOD GLUCOSE; BLOOD PRESSURE; BOSTON; BRAIN ISCHEMIA; CATECHOLAMINES; CEREBROVASCULAR ACCIDENT; CORONARY CIRCULATION; ELECTROCARDIOGRAPHY; EPILEPSIES, MYOCLONIC; FEMALE; FOLLOW-UP STUDIES; HEART RATE; HUMANS; MALE; MERRF SYNDROME; MIDDLE AGED; MITOCHONDRIA, HEART; MITOCHONDRIAL MYOPATHIES; MYOCARDIAL REPERFUSION; MYOCARDIUM; REST; STATISTICS; SYNDROME; THYROTROPIN; TOMOGRAPHY, EMISSION-COMPUTED;

EID: 0037614912     PISSN: 09546928     EISSN: None     Source Type: Journal    
DOI: 10.1097/00019501-200305000-00002     Document Type: Article

References (35)

1. Lodi R, Cooper JM, Bradley JL, Manners D, Styles P, Taylor DJ, et al. Deficit of in vivo mitochondrial ATP production in patients with Friedreich ataxia. Proc Natl Acad Sci USA 1999; 96:11492-11495.
2. Brega A, Narula J, Arbustini E. Functional, structural, and genetic mitochondrial abnormalities in myocardial disease. J Nucl Cardiol 2001; 8:89-97.
3. Simon DK, Johns DR. Mitochondrial disorders: clinical and genetic features. Annu Rev Med 1999; 50:111-127.
4. Anan R, Nakagawa M, Miyata M, Higuchi I, Nakao S, Suehara M, et al. Cardiac involvement in mitochondrial diseases. A study on 17 patients with documented mitochondrial DNA defects [see comments]. Circulation 1995; 91:955-961.
5. Sato W, Tanaka M, Sugiyama S, Nemoto T, Harada K, Miura Y, et al. Cardiomyopathy and angiopathy in patients with mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Am Heart J 1994; 128:733-741.
6. Williams RS. Canaries in the coal mine: mitochondrial DNA and vascular injury from reactive oxygen species [editorial, comment]. Circ Res 2000; 86:915-916.
7. Williams RS. Cardiac involvement in mitochondrial diseases, and vice versa [editorial, comment]. Circulation 1995; 91:1266-1268.
8. Czernin J, Muller P, Chan S, Brunken RC, Porenta G, Krivokapich J, et al. Influence of age and hemodynamics on myocardial blood flow and flow reserve. Circulation 1993; 88:62-69.
9. Tritschler HJ, Packer L, Medori R. Oxidative stress and mitochondrial dysfunction in neurodegeneration. Biochem Mol Biol Int 1994; 34:169-181.
10. Tawakol A, Forgione MA, Stuehlinger M, Alpert NM, Cooke JP, Loscalzo J, et al. Homocysteine impairs coronary microvascular dilator function in humans. J Am Coll Cardiol 2002; 40:1051-1058.
11. Gewirtz H, Skopicki HA, Abraham SA, Castano H, Dinsmore RE, Alpert NM, et al. Quantitative PET measurements of regional myocardial blood flow: observations in humans with ischemic heart disease. Cardiology 1997; 88:62-70.
12. Skopicki HA, Abraham SA, Weissman NJ, Mukerjee AK, Alpert NM, Fischman AJ, et al. Factors influencing regional myocardial contractile response to inotropic stimulation. Analysis in humans with stable ischemic heart disease. Circulation 1996; 94:643-650.
13. Skopicki HA, Abraham SA, Picard MH, Alpert NM, Fischman AJ, Gewirtz H. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease [published erratum appears in Circulation 97:414]. Circulation 1997; 96:3346-3352.
14. Rosenspire KC, Schwaiger M, Magner TJ, Hutchins GD, Sutorik A, Kuhl DE. Metabolic fate of 13-N-ammonia in human and canine blood. J Nucl Med 1990; 31:163-167.
15. Gewirtz H, Fischman AJ, Abraham SA, Gilson M, Strauss HW, Alpert NM. Positron emission tomographic measurements of absolute regional myocardial blood flow permits identification of nonviable myocardium in patients with chronic myocardial infarction. J Am Coll Cardiol 1994; 23:851-859.
16. Feigl EO. Coronary physiology. Physiol Rev 1983; 63:1-205.
17. James AM, Wei YH, Pang CY, Murphy MP. Altered mitochondrial function in fibroblasts containing MELAS or MERRF mitochondrial DNA mutations. Biochem J 1996; 318:401-407.
18. Chinnery PF, Howell N, Lightowlers RN,Turnbull DM. Molecular pathology of MELAS and MERRF. The relationship between mutation load and clinical phenotypes. Brain 1997; 120:1713-1721.
19. Sciacco M, Bonilla E, Schon EA, DiMauro S, Moraes CT. Distribution of wild-type and common deletion forms of mtDNA in normal and respiration-deficient muscle fibers from patients with mitochondrial myopathy. Hum Mol Genet 1994; 3:13-19.
20. Takahashi S, Tohgi H, Yonezawa H, Obara S, Nagane Y. Cerebral blood flow and oxygen metabolism before and after a stroke-like episode in patients with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS). J Neurol Sci 1998; 158:58-64.
21. Nariai T, Ohno K, Ohta Y, Hirakawa K, Ishii K, Senda M. Discordance between cerebral oxygen and glucose metabolism, and hemodynamics in a mitochondrial encephalomyopathy, lactic acidosis, and strokelike episode patient. J Neuroimaging 2001; 11:325-329.
22. Sano M, Ishii K, Momose Y, Uchigata M, Senda M. Cerebral metabolism of oxygen and glucose in a patient with MELAS syndrome. Acta Neurol Scand 1995; 92:497-502.
23. Ooiwa Y, Uematsu Y, Terada T, Nakai K, Itakura T, Komai N, et al. Cerebral blood flow in mitochondrial myopathy, encephalopathy, lactic acidosis, and strokelike episodes. Stroke 1993; 24:304-309.
24. Berkovic SF, Carpenter S, Evans A, Karpati G, Shoubridge EA, Andermann F, et al. Myoclonus epilepsy and ragged-red fibres (MERRF). 1. A clinical, pathological, biochemical, magnetic resonance spectrographic and positron emission tomographic study. Brain 1989; 112:1231-1260.
25. Bank W, Chance B. Diagnosis of defects in oxidative muscle metabolism by non-invasive tissue oximetry. Mol Cell Biochem 1997; 174:7-10.
26. Ide T, Tsutsui H, Hayashidani S, Kang D, Suematsu N, Nakamura K, et al. Mitochondrial DNA damage and dysfunction associated with oxidative stress in failing hearts after myocardial infarction. Circ Res 2001; 88:529-535.
27. Loke KE, McConnell PI, Tuzman JM, Shesely EG, Smith CJ, Stackpole CJ, et al. Endogenous endothelial nitric oxide synthase-derived nitric oxide is a physiological regulator of myocardial oxygen consumption. Circ Res 1999; 84:840-845.
28. Liu S, Beckman J, Ku D. Peroxynitrite, a product of superoxide and nitric oxide, produces coronary vasorelaxation in dogs. J Pharmacol Exp Ther 1994; 268:1114-1121.
29. Duvernoy CS, Meyer C, Seifert-Klauss V, Dayanikli F, Matsunari I, Rattenhuber J, et al. Gender differences in myocardial blood flow dynamics: lipid profile and hemodynamic effects. J Am Coll Cardiol 1999; 33:463-470.
30. Shah A, Schelbert HR, Schwaiger M, Hansen H, Selin C. Measurement of regional myocardial blood flow with N-13 ammonia and positron emission tomography in intact dogs. J Am Coll Cardiol 1985; 5:92-100.
31. Krivokapich J, Smith GT, Huang SC, Hoffman EJ, Ratib O, Phelps ME, et a. 13-N Ammonia myocardial imaging at rest and with exercise in normal volunteers: quantification of absolute myocardial perfusion with dynamic positron emission tomography. Circulation 1989; 80:1328-1337.
32. Hutchins GD, Schwaiger M, Rosenspire KC, Krivokapich J, Schelbert HR, Kuhl D. Noninvasive quantification of regional myocardial blood flow in the human heart using N-13 ammonia and dynamic positron emission tomographic imaging. J Am Coll Cardiol 1990; 15:1032-1042.
33. Bol A, Melin J, Vanoverschelde J, Baudhuin T, Vogelaers D, De Pauw M, et al. Direct comparison of 13-N-ammonia and 15-O-water estimates of perfusion and quantification of regional myocardial blood flow by microspheres. Circulation 1993; 87:512-525.
34. Dutka DP, Donnelly JE, Palka P, Lance A, Nunez DJ, Nihoyannopoulos P. Echocardiographic characterization of cardiomyopathy in Friedreich's ataxia with tissue Doppler echocardiographically derived myocardial velocity gradients. Circulation 2000; 102:1276-1282.
35. Lodi R, Rajagopalan B, Blamire AM, Cooper JM, Davies OH, Bradley JL, et al. Cardiac energetics are abnormal in Friedreich ataxia patients in the absence of cardiac dysfunction and hypertrophy: an in vivo 31P magnetic resonance spectroscopy study. Cardiovasc Res 2001; 52:111-119.